Spondyloarthropathies News

Tuesday, November 18, 2008 Centocor's Golimumab Gives Durable Skin, Joint Relief in Psoriatic Arthritis, ACR Studies Say
More than half of active psoriatic arthritis patients receiving subcutaneous injections of 50 mg or 100 mg of golimumab (CNTO 148) every 4 weeks showed improvements that lasted through 1 year in the joint and skin symptoms...

Friday, November 07, 2008 Studies Confirm, Extend Uses of MRI in Spondyloarthropathies
Severe romanus lesions in patients with back pain who are younger than 51 are very specific for spondyloarthropathy, and an MRI of just the sacroiliac joint is generally enough to diagnose nonradiographic axial SpA, regardless of the location of the back pain...

Thursday, July 17, 2008 Classification and Categorization of Psoriatic Arthritis
Researchers in the field of psoriatic arthritis are working to overhaul Moll and Wright’s criteria for the classification and categorization of the disease…

Thursday, July 03, 2008 Centocor Requests Approval From FDA of Golimumab for the Treatment of RA, Psoriatic Arthritis, and Ankylosing Spondylitis
Centocor submitted a Biologics License Application to the US FDA requesting the approval of golimumab, a human anti-TNFα monoclonal antibody, as a monthly subcutaneous treatment for adults with active forms of RA, PsA, and AS...

Friday, May 23, 2008 Iatrogenic Problems Reported in Low Back Pain, Osteoporosis Patients at AACE Meeting
Cases of iatrogenic Cushing's syndrome (CS) from intra-articular triamcinolone and iatrogenic hypercalcemia from combined teriparatide-hydrochlorothiazide were reported at the American Association of Clinical Endocrinologists 2008 meeting...

Tuesday, May 13, 2008 Incidence and Prevalence of Psoriatic Arthritis
Researchers found geographic variations in the occurrence of PsA, but methodological issues make interpreting epidemiologic data difficult…

Tuesday, April 08, 2008 Does Physical Therapy Still Have a Place in the Treatment of Ankylosing Spondylitis?
Researchers believe that pharmacological advancements in the treatment of ankylosing spondylitis do not replace traditional physical therapy programs…

Tuesday, March 25, 2008 Yeast Antibodies Predict More Severe AS
Patients with seronegative spondyloarthropathies, especially AS, who have high levels of antibodies to Saccharomyces cerevisiae are likely to have more severe disease and to need more anti-TNF therapy...

Tuesday, March 25, 2008 Diagnosis Delay in Patients with Ankylosing Spondylitis
Researchers have established new diagnostic criteria for ankylosing spondylitis in an effort to minimize the diagnosis delay in AS...

Tuesday, January 15, 2008 Evaluation of a Quantitative Scoring of Enthesitis in Ankylosing Spondylitis
Researchers assessed the validity of an enthesitis index calculated by algometric pressure pain threshold scoring...